E (2015-2019)

STUDIES ON CONDITIONS and RELATED ARTICLES 2015-2019

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
^Articles/Studies in 2010-2014 List
>Information in Another Section


EATING DISORDERS-GENERAL
EBOLA
ECLAMPSIA/PRE-ECLAMPSIA
ECZEMA+
EDEMA*+
>EHLERS-DANLOS SYNDROME+ (See News Articles 2010-2018)
ELECTRICAL STIMULATION
ELECTROCONVULSIVE THERAPY
EMBRYOS/FETAL DEVELOPMENT/PLACENTAL DEVELOPMENT +
ENCEPHALITIS+
ENCEPHALOMYELITIS/EAE*+
ENDOMETRIOSIS/ENDOMETRIUM+
ENDOTOXEMIA (Low-grade inflammation from circulating endotoxins)
ENERGY DRINKS

ENTOURAGE EFFECT (See PHYTOCANNABINOIDS and ENDOCANNABINOIDS)
EPIDERMOLYSIS BULLOSA
EPILEPSY/SEIZURES* (See Also EPIDIOLEX in PHYTOCANNABINOIDS)
EPSTEIN-BARR^
ESSENTIAL TREMOR (See Also News Articles 2010-2018)
ETHICS and CANNABIS
EXERCISE and the ENDOCANNABINOID SYSTEM*+


EATING DISORDERS-GENERAL
Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and
Psychological Outcomes: Mediation by Endocannabinoids (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981584/
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies (abst–2018) https://www.nature.com/articles/s41401-018-0081-z
Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systems (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0024320519305016?via%3Dihub


EBOLA
Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591006/
Cannabidiol: a potential treatment for post Ebola syndrome? (link to PDF– 2016)
http://www.ijidonline.com/article/S1201-9712(16)31177-8/abstract
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (full–2017)
https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full


ECLAMPSIA/PRE-ECLAMPSIA
Decreased circulating anandamide levels in preeclampsia (download–2015) https://core.ac.uk/download/pdf/78472108.pdf
[268-POS]: Placental expression of the endocannabinoid system in preeclampsia  (abst–2015) http://www.sciencedirect.com/science/article/pii/S2210778914003754
A case of cannabinoid hyperemesis syndrome with heliobacter pylori and pre-eclampsia during pregnancy (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/28723278


ECZEMA +
Cannabis and Dr Piffard-A Century Ahead of the Curve (article–2016) http://archderm.jamanetwork.com/article.aspx?articleid=2547236
The Endocannabinoid System and Its Role in Eczematous Dermatoses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28098721
Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and  alleviate clinical symptoms of atopic eczema (abst–2017)  http://www.jdsjournal.com/article/S0923-1811(16)31025-8/fulltext
Common Allergens Prevalent in and Around Ambala, Haryana: An Intradermal Study among Patients with Asthma and Allergic Rhinitis and Atopic Dermatitis (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052743/


EDEMA*+
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25625355
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25833102
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
top

A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26376816
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26463937
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015)  ttp://www.sciencedirect.com/science/article/pii/S0028390815001574
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst-2016) http://link.springer.com/chapter/10.1007/978-3-319-18497-5_24

Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017)  http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28707493
An endocannabinoid uptake inhibitor from black pepper exerts pronounced antiinflammatory effects in mice (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role  of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway (abst–2017) https://link.springer.com/article/10.1007%2Fs12035-017-0792-z
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29079445
Bilateral multiple exudative retinal detachments and macular edema in a patient  diagnosed with synthetic cannabinoid (Bonzai) intoxication (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29275529
Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury (full-2018)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-018-1166-9
The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors (full–2018) https://www.frontiersin.org/articles/10.3389/fnmol.2018.00180/full
A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats. (abst 2018)
https://www.sciencedirect.com/science/article/pii/S0006899318303330?via%3Dihub
Monoacylglycerol Lipase Inhibitor is Safe when Combined with Delayed r-tPA
Administration in Treatment of Stroke (abst–2018) https://link.springer.com/article/10.1007/s10753-018-0848-x

JZL184, as a monoacylglycerol lipase inhibitor, down-regulates inflammation in a
cannabinoid pathway dependent manner (abst–2018) 
https://www.sciencedirect.com/science/article/pii/S075333221735014X

Clinical effects of reported synthetic cannabinoid exposure in patients admitted to the intensive care unit (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30146395

Cannabinoid receptor 2 agonist attenuates blood-brain barrier damage in a rat model of intracerebral hemorrhage by activating the Rac1 pathway (abst–2018) https://www.spandidos-publications.com/ijmm/42/5/2914

Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain (abst–2018) https://www.semanticscholar.org/paper/Effect-of-cannabidiolic-acid-and-on-hyperalgesia-in-RockLimebeer/4deb319acbbb3cd406f695b92a00bc566615a396


ELECTRICAL STIMULATION
Endocannabinoid CB1 receptors are involved in antiepileptogenic effect of low frequency electrical stimulation during perforant path kindling in rats (abst–2018) https://www.sciencedirect.com/science/article/pii/S0920121117304291?via%3Dihub


ELECTROCONVULSIVE THERAPY*+
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of  patients with major depression: a preliminary prospective study (abst–2017)  https://link.springer.com/article/10.1007%2Fs00406-017-0789-7
Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study (link to download–2018) http://discovery.ucl.ac.uk/10059854/


EMBRYOS/FETAL DEVELOPMENT/PLACENTAL DEVELOPMENT+
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo (full–2015) http://www.springerplus.com/content/4/1/804
Endocannabinoid signaling in female reproductive events: a potential therapeutic target? (full–2015)  http://www.tandfonline.com/doi/full/10.1517/14728222.2015.1062878
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (full–2015) http://www.hindawi.com/journals/mi/2015/850471/
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781665/
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/
Use of paracetamol during pregnancy and child neurological development (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/dmcn.12745/full
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (full–2015)  http://www.fertstert.org/article/S0015-0282(15)00440-9/fulltext
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor (full–2015) http://www.reproduction-online.org/content/150/6/463.long
Epigenetic Effects of Cannabis Exposure (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789113/
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912947/
Lipid abundance in zebrafish embryos is regulated by complementary actions of the Endocannabinoid System and Retinoic Acid Pathway (full–2015) https://academic.oup.com/endo/article/156/10/3596/2422925

Progesterone and anandamide in pregnancy loss (full–2015) http://www.placentajournal.org/article/S0143-4004%2815%2900515-9/fulltext
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and  psychological processes (click “researchgate” for download–2015) https://scholar.google.com/scholar?q=Longterm+consequences+of+perinatal+and+adolescent+cannabinoid+exposure+on+neural+and+psychological+processes&hl=en&as_sdt=0&as_vis=1&oi=scholart 

Anandamide restricts uterine stromal differentiation and is critical for complete decidualization (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25960165
Anandamide and Decidual Remodeling: COX-2 oxidative metabolism as a key regulator (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26335727
The endocannabinoid 2-arachidonoylglycerol dysregulates the synthesis of proteins by the human syncytiotrophoblast (abst–2015) http://www.sciencedirect.com/science/article/pii/S1388198115002309
top
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation (full–2016) https://academic.oup.com/cercor/article-lookup/doi/10.1093/cercor/bhw052
Exocannabinoids effect on in vitro bovine oocyte maturation via activation of AKT and  ERK1/2 (full–2016) http://www.reproduction-online.org/content/152/6/603.long
Sexually-dimorphic alterations in cannabinoid receptor density depend upon  prenatal / early postnatal history (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184775/
A role for the endocannabinoid system in premature luteal regression and progesterone withdrawal in lipopolysaccharide-induced early pregnancy loss model  (full–2016) https://academic.oup.com/molehr/article/22/11/800/2418643
Dynamic of expression and localization of cannabinoid-degrading enzymes FAAH and MGLL in relation to CB1 during meiotic maturation of human oocytes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26948343

The endocannabinoid system: an emergent player in human placentation (abst–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300260
Endocannabinoids participate in placental apoptosis induced by hypoxia inducible factor-1 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488203
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27731508
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27959272
Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK
phosphorylation (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816306612
Conceptus development and transcriptome at preimplantation stages in lactating dairy  cows of distinct genetic groups and estrous cyclic statuses (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27016828
Immunohistochemistry Detected and Localized Cannabinoid Receptor Type 2 in Bovine  Fetal Pancreas at Late Gestation (full–2017)  http://www.ejh.it/index.php/ejh/article/view/2761/2667
A Putative ‘Pre-Nervous’ Endocannabinoid System in Early Echinoderm Development (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866581/
Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for
Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/
What effects—if any—does marijuana use during pregnancy have on the fetus or child?  (full–2017) http://www.mdedge.com/jfponline/article/141775/pediatrics/what-effects-if-any-does-marijuana-use-during-pregnancy-have
Overactive type 2 cannabinoid receptor induces meiosis in fetal gonads and impairs  ovarian reserve (full–2017)  http://www.nature.com/cddis/journal/v8/n10/full/cddis2017496a.html?foxtrotcallback=true
The Cannabinoid Receptor Interacting Proteins 1 of zebrafish are not required for  morphological development, viability or fertility (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28687732
The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650704/
Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces  Trophoblast Dysfunction (full–2017) https://www.karger.com/Article/FullText/477603
Evidence for CB2 receptor involvement in LPS-induced reduction of cAMP intracellular levels in uterine explants from pregnant mice: pathophysiological implications (full–2017) https://academic.oup.com/molehr/article/23/7/500/3778489
Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636690/
Maternal alcohol exposure during mid-pregnancy dilates fetal cerebral arteries via
endocannabinoid receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517095/
Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4 (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706968/
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem CellDerived Neurons (full–2017)
https://www.karger.com/Article/FullText/477762
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic  Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292

CB1 cannabinoid receptor drives oocyte maturation and embryo development via  PI3K / Akt and MAPK pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28428264
The endocannabinoid system expression in the female reproductive tract is modulated by estrogen (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0960076017301887
Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28847562
Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29106691
EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29138223
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068
Interpretation of cannabis findings in the hair of very young children: mission impossible (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29189142
The synthetic cannabinoid WIN-55,212-55,212 induced-apoptosis in cytotrophoblasts  cells by a mechanism dependent on CB1 receptor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28495606
Metformin attenuates susceptibility to inflammation-induced preterm birth in mice with  higher endocannabinoid levels (abst–2017) https://academic.oup.com/biolreprod/advance-article-abstract/doi/10.1093/biolre/iox164/4693831?redirectedFrom=fulltext
Neuro-glial cannabinoid receptors modulate signaling in the embryonic avian retina (full-2018) http://www.sciencedirect.com/science/article/pii/S0197018617302280?via%3Dihub
Cannabinoid Receptor Type 1 Expression in the Developing Avian Retina:
Morphological and Functional Correlation With the Dopaminergic System (full–2018) https://www.frontiersin.org/articles/10.3389/fncel.2018.00058/full
Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆9-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043604/
Marijuana use during and after pregnancy and association of prenatal use on birth
outcomes: A population-based study (full–2018) http://pediatrics.aappublications.org/content/142/3/e20181889.long
Sex Difference: What does cannabis do to the brain before birth? (full–2018) https://elifesciences.org/articles/41229

A cannabinoid receptor type 1 (CB1R) agonist enhance the developmental neurotoxicity of acetaminophen (paracetamol) (full–2018) https://academic.oup.com/toxsci/article/166/1/203/5079325

Transcriptomic Characterization of the Human Habenula Highlights Drug Metabolism and the Neuroimmune System (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220030/

Sex-dependent effects of in utero cannabinoid exposure on cortical function (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162091/
Drug Use during Pregnancy and its Consequences: A Nested Case Control Study on
Severe Maternal Morbidity. (full in English, abst in Portuguese–2018)
https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0038-1667291

Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring (link to PDF–2018) https://www.researchgate.net/publication/326224957_Maternal_and_paternal_cannabis_use_during_pregnancy_and_the_risk_of_psychotic-like_experiences_in_the_offspring
Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study (link to PDF–2018) https://www.researchgate.net/publication/324093683_Marijuana_use_during_and_after_pregnancy_and_association_of_prenatal_use_on_birth_outcomes_A_population-based_study
An epidemiological, developmental and clinical overview of cannabis use during pregnancy (link to download–2018) https://www.dfaf.org/wp-content/uploads/2018/09/El_Marroun-et-al.-2018.pdf
A Modern Conundrum for the Pediatrician: The Safety of Breast Milk and the Cannabis Using Mother (article–2018) http://pediatrics.aappublications.org/content/142/3/e20181921.long
Endocannabinoid Signaling in Embryonic Neuronal Motility and Cell–Cell Contact –
Role of mGluR5 and TRPC3 Channels (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0306452218301131
Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on
Zebrafish Larvae (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29634460
Evaluation of Bisphenol A influence on endocannabinoid system in pregnant women (abst-2018)  https://www.sciencedirect.com/science/article/pii/S0045653518306234
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29705007
CatSper: A Unique Calcium Channel of the Sperm Flagellum (abst–2018) https://www.sciencedirect.com/science/article/pii/S2468867318300221
Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the
Growth and Development of Their Offspring in Early Childhood (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29694295

Additive drug-specific and sex-specific risks associated with co-use of marijuana and
tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003-2015) (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0892036218300266?via%3Dihub

Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29694295

Sex specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signaling (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29968249

Developmental and behavioral effects in neonatal and adult mice following prenatal activation of endocannabinoid receptors by capsaicin (abst–2018) https://www.nature.com/articles/s41401-018-0073-z

Effect of chronic THC administration in the reproductive organs of male mice, spermatozoa and in vitro fertilization (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303150

Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior (abst–2018) https://www.sciencedirect.com/science/article/pii/S0892036218300242?via%3Dihub

Effects of feeding a source of omega-3 fatty acid during the early postpartum period on the endocannabinoid system in the bovine endometrium (abst–2018) https://www.sciencedirect.com/science/article/pii/S0093691X18305880?via%3Dihub
Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos (abst–2018) https://www.sciencedirect.com/science/article/pii/S0009279718302163?via%3Dihub

Gestational Age-Dependent Interplay between Endocannabinoid Receptors and Alcohol in Fetal Cerebral Arteries (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497414/

Marijuana Use in Pregnancy: An Updated Look at Marijuana Use and Its Impact on Pregnancy (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30531376

Multigenerational consequences of early-life cannabinoid exposure in zebrafish (abst–2019) https://www.sciencedirect.com/science/article/pii/S0041008X18305805?via%3Dihub
Ethanol and cannabinoids interact to alter behavior in a zebrafish fetal alcohol spectrum disorder model (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30648819

Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues (abst–2019) https://www.sciencedirect.com/science/article/pii/S089062381730518X?via%3Dihub

Assessing the acute effects of prenatal synthetic cannabinoid exposure on murine fetal brain vasculature using optical coherence tomography (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30887665

Herring roe oil supplementation alters microglial cell gene expression and reduces peripheral inflammation after immune activation in a neonatal piglet model (abst–2019) https://www.sciencedirect.com/science/article/pii/S0889159119301606?via%3Dihub

Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0306453018308412?via%3Dihub

Mice Missing Cnr1 and Cnr2 Show Implantation Defects (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30776303


ENCEPHALITIS+
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent – case report (download–2016) http://www.mppt.hu/folyoirat/1/abstract/? vol=18&issue=3&elsooldal=162


ENCEPHALOMYELITIS/EAE*+
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent energy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full-2015)
http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0306452215000858
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537576
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26189763
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ(9)-tetrahydrocannabinol acting through CB1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26590655
top
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0603-x

Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism (full–2017) https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0783-4
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor  Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral  blood mononuclear cells of progressive multiple sclerosis patients (abst–2017)  http://www.jns-journal.com/article/S0022-510X(17)30392-1/fulltext
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28757328
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617302212
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831753/

Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells (full–2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.01782/full

The inhibition of CB1 receptor accelerates the onset and development of EAE possibly by regulating microglia/macrophages polarization (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0165572817304678

Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune Encephalomyelitis (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29512125

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30291491

Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome (abst–2019) https://www.sciencedirect.com/science/article/pii/S0889159119306476?via%3Dihub


ENDOMETRIOSIS/ENDOMETRIUM+
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis (full–2016)  https://academic.oup.com/humrep/article/32/1/175/2448170
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (full–2016) http://journals.sagepub.com/doi/full/10.1177/1933719116630414

Anandamide interferes with human endometrial stromal-derived cell differentiation: An effect dependent on inhibition of cyclooxygenase-2 expression and prostaglandin E2 release (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945481
Cannabinoid receptor 1 contributes to sprouted innervation in endometrial ectopic  growth through mitogen-activated protein kinase activation (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28322749
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (abst–2016)  http://journals.sagepub.com/doi/full/10.1177/1933719116630414
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/
Endocannabinoids modulate apoptosis in endometriosis and adenomyosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28549792
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis (abst–2018) https://www.sciencedirect.com/science/article/pii/S1521693418300397?via%3Dihub
Endocannabinoids as endometrial inflammatory markers in lactating Holstein cows  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29542183

Self-management strategies amongst Australian women with endometriosis: a national online survey (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332532/

Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis (full–2019) https://www.hindawi.com/journals/bmri/2019/5468954/
Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2 (abst–2019) https://www.sciencedirect.com/science/article/pii/S0300483X18303834?via%3Dihub


ENDOTOXEMIA
Metabolic endotoxemia affects about 33% of Americans
Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of Endotoxemia (link to full-2017) https://www.hindawi.com/journals/mi/2017/4315412/
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial (link to PDF–2017)  https://www.pubfacts.com/detail/29179781/
Low-fat-yogurt-consumption-reduces-biomarkers-of-chronic-inflammation-and-inhibitsmarkers-of-endoto
TLR4 Receptor Induces 2-AG–Dependent Tolerance to Lipopolysaccharide and Trafficking of CB2 Receptor in Mast Cells (abst-2019) https://www.jimmunol.org/content/202/8/2360.long


ENERGY DRINKS
Consuming energy drinks at the age of 14 predicted legal and illegal substance use at 16 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27513298
The role of energy drink consumption in the intention to initiate marijuana use among adolescents (abst–2019)  https://www.sciencedirect.com/science/article/abs/pii/S0306460319301285?via%3Dihub


EPIDERMOLYSIS BULLOSA*+
Self-initiated use of topical cannabidiol oil for epidermolysis bullosa (full–2018) beyondthc.com
Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States (abst–2018) http://journals.sagepub.com/doi/abs/10.1177/1203475418808761?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cmsa


EPILEPSY/SEIZURES*+
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon induced seizures (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/prp2.100/full
Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine (full–2015) http://www.hindawi.com/journals/mi/2015/523418/
top

Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284516/
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499434/
Phytocannabinoids and epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety-like behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Cannabinoids: is there a potential treatment role in epilepsy? (full–2015) http://informahealthcare.com/doi/pdf/10.1517/14656566.2015.1074181
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598436/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full-2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Homer Protein-Metabotropic Glutamate Receptor Binding Regulates Endocannabinoid Signaling and Affects Hyperexcitability in a Mouse Model of Fragile X Syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25740522
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (full–2015) http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/epi.13060/full
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/divclasstitlemarijuana-a-time-honored-but-untested-treatment-forepilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666428/
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
Neuroprotective effects of trans-caryophyllene against kainic Acid induced seizure activity and oxidative stress in mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25417010
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25592741
Options for pharmacoresistant epilepsy in children: when medications don’t work (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25658218
A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25726258
top

Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid transport and degradation in guinea pigs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25769371
Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796567
Withdrawal Seizures Seen In the Setting of Synthetic Cannabinoid Abuse (abst–2015)  http://www.ajemjournal.com/article/S0735-6757%2815%2900169-2/abstract
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845492
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25882081
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25891509
Influence of arachidonyl-2′-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904357
Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933961
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
JWH-018 impairs sensorimotor functions in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25987201
Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26135674
Changes over time of cannabinoid receptor 1 in hippocampus of status epilepticus rats (abst in English–2015) http://www.ncbi.nlm.nih.gov/pubmed/26168676 (abst in Chinese) http://zhyxzz.yiigle.com/CN112137201505/125169.htm?locale=zh_CN
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
top
Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26283212
Marijuana Use in Epilepsy: The Myth and the Reality (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299273
Issues and promise in clinical studies of botanicals with anticonvulsant potential (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26341963
Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11 (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26360322
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26370914
Cannabis and Endocannabinoid Signaling in Epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408165
Polypharmacology Shakes Hands with Complex Aetiopathology (abst-2015) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(15)00171-6
Cannabidiol as potential treatment in refractory pediatric epilepsy (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26567560
The effects of adolescent cannabinoid exposure on seizure susceptibility and lethality in adult male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711091
Convulsant effects of high efficacy synthetic cannabinoid JWH-018 in mice (abst-2015) http://www.fasebj.org/content/29/1_Supplement/614.7.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole induced seizure severity in Wistar rats (abst–2015) http://www.epires-journal.com/article/S0920-1211(16)30131-0/abstract
An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26555732
The Pharmacological Basis of Cannabis Therapy for Epilepsy (full–2016) http://jpet.aspetjournals.org/content/early/2016/01/19/jpet.115.230151.long
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling (full–2016) http://www.nature.com/articles/srep21931
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (full–2016) https://peerj.com/articles/2081/
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (full–2016) http://www.sciencedirect.com/science/article/pii/S1059131116000054
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Fatty Acid Binding Proteins (FABPs) are Intracellular Carriers for Δ9-
Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (full–2016)  http://www.jbc.org/content/290/14/8711.full
Investigational new drugs for focal epilepsy (full–2016)  http://www.tandfonline.com/doi/full/10.1517/13543784.2016.1110144
Synthetic cannabinoids revealing adrenoleukodystrophy (full–2016) http://www.sciencedirect.com/science/article/pii/S0967586815004567
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.phpjournal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures (full–2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30852-X
Turning Up the Heat on Endocannabinoid Signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106110/
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043219/
Medical Marijuana for Epilepsy? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911937/
Investigational new drugs for focal epilepsy (full–2016) http://www.tandfonline.com/doi/full/10.1517/13543784.2016.1110144
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958898/
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26804027
Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures  (full–2016) http://www.epilepsybehavior.com/article/S1525-5050(15)00695-2/fulltext
Cannabis and epilepsy: An ancient treatment returns to the fore (full–2016)
https://www.researchgate.net/publication/311737721_Cannabis_and_epilepsy_An_ancient_treatment_returns_to_the_fore
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid
Receptor Agonists with Analytical Confirmation (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135680/
Cannabis and Cannabinoids (1st page–2016)  http://jamanetwork.com/journals/jama/article-abstract/2592497

Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616300069
Plant-Derived and Endogenous Cannabinoids in Epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26892745
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970948
Cannabidiol and epilepsy: rationale and therapeutic potential (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816301797
LACTIC ACIDOSIS: A RARE MANIFESTATION OF SYNTHETIC MARIJUANA INTOXICATION (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27159480
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
CB1 Receptor Antagonism Prevents Long-Term Hyperexcitability after Head Injury by of Dynorphin-KOR System and mGluR5 in Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262683
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27285147
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
From cannabis to cannabidiol to treat epilepsy, where are we? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27587196
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916306161
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Endogenous cannabinoid system alterations and their role in epileptogenesis after brain injury in rat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27810514
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116303092
Using Medical Marijuana to Stop Childhood Seizures (news & abstract–2016) http://neurosciencenews.com/thc-cbd-childhood-seizures-3618/
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of  Mesial Temporal Lobe Epilepsy (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00131/full
A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with  Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy (full–2017) http://www.mdpi.com/1422-0067/18/5/900
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent  Epilepsy? (full–2017) http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
An Australian nationwide survey on medicinal cannabis use for epilepsy: History of  antiepileptic drug treatment predicts medicinal cannabis use (full–2017)  http://www.epilepsybehavior.com/article/S1525-5050(17)30073-2/fulltext
Effects of arachidonyl-2′-chloroethylamide (ACEA) on the protective action of various  antiepileptic drugs in the 6-Hz corneal stimulation model in mice (full–2017)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183873
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions  through conditional genetic rescue in forebrain GABAergic neurons (full–2017)  https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate after-discharges and restores seizure-induced impairment of short and long-term synaptic plasticity (full–2017) https://www.nature.com/articles/s41598-017-11606-1
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392943
The Role of BK Channels in Antiseizure Action of the CB1 Receptor Agonist ACEA in
Maximal Electroshock and Pentylenetetrazole Models of Seizure in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603872/
Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165363
A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus—A case report and review of the literature (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721953/
The current status of artisanal cannabis for the treatment of epilepsy in the United States (full–2017) https://www.projectcbd.org/sites/projectcbd/files/downloads/the_current_status_of_artisanal_cannabis_for_the_treatment_of_epilepsy_in_the_united_states.pdf 
Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424589/
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans (full–2017)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738750/
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic
Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study
(full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440319/
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome (full–2017)
https://www.nejm.org/doi/10.1056/NEJMoa1611618?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786486/
Recent advances in epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533817/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and 
pharmacological consequences (link to download–2017)   http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls (link to download–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29208697
Interaction between urethane and cannabinoid CB1 receptor agonist and antagonist in penicillin-induced epileptiform activity (click “Free Full PDF” for download–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691717
New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic  Cannabinoids (1st page-2017)  http://www.psychosomaticsjournal.com/article/S0033-3182(16)30124-4/fulltext
Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30666-7/fulltext
Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30622-9/fulltext
Social factors in marijuana use for medical and recreational purposes (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
Pharmacology of cannabinoids in the treatment of epilepsy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28087250
Cannabinoids in treatment-resistant epilepsy: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188044
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy,  epileptogenesis, and epilepsy-related neuroprotection (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30531-5/fulltext
Endocannabinoid-dependent protection against kainic acid-induced long-term  alteration of brain oscillations in guinea pigs (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28192082
Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30731-4/fulltext
The Direct Actions of Cannabidiol and 2-Arachidonoyl Glycerol at GABAA Receptors  (abst–2017) http://www.sciencedirect.com/science/article/pii/S1043661816311392
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/28276775
Cannabis and epilepsy (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(17)30041-0/fulltext
Cannabinoids as hippocampal network administrators (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301405?via%3Dihub
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first  half of 2015 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28421836
Neurological aspects of medical use of cannabidiol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28412918
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28454984
Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP) (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28478594
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced  Suppression of Excitation in the Anterior Cingulate Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28520841
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic  stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/19591935
Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in  developing rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28691158
Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment  (abst–2017) http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30438-3/fulltext
Antiepileptic drugs in clinical development: differentiate or die? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28799516
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(17)30322-0/abstract
The potential role of cannabinoids in epilepsy treatment (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28845714
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo 
Neurotoxic Effects of Paraoxon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28803438
Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency  stabilization in Colorado: a P SCAN Cohort (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28862050
Cannabis use in Epilepsy. Current situation in Argentina and abroad (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28898306
Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28945457
Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A 
case series and review of the literature (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29037744
Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid  Receptor Agonists: From Horizon Scanning to Notification (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29038156
Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB1  receptors and glutamatergic transmission (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0041008X17304155
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Cannabinoid receptor 1/2 double-knockout mice develop epilepsy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29105060
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29171003
Simple and fast gas-chromatography mass spectrometry assay to assess delta 9-
tetrahydrocannabinol and cannabidiol in dogs treated with medical cannabis for canine epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29173160
Cannabinoids for epilepsy: What do we know and where do we go? (abst–2017)   https://www.ncbi.nlm.nih.gov/pubmed/29214639
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center (full–2018)
http://www.epilepsybehavior.com/article/S1525-5050(18)30009-X/fulltext

Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin (full–2018)
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00032/full
Positron emission tomography imaging of cerebral glucose metabolism and type 1
cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys (full–2018)
https://onlinelibrary.wiley.com/doi/full/10.1111/epi.14059
Therapeutic potential of medicinal marijuana: an educational primer for health care
professionals (full–2018) 
https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-articleDHPS
Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719834/
Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse
Model of Acute Epilepsy (full–2018) 
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00067/full
Pediatric Death Due to Myocarditis After Exposure to Cannabis (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965161/
Review of the neurological benefits of phytocannabinoids (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938896/
Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as
Cannabidiol — Utah, 2017–2018 (full–2018) 
https://www.cdc.gov/mmwr/volumes/67/wr/mm6720a5.htm?s_cid=mm6720a5_w
Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian
Community (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033872/
Cannabis for pediatric epilepsy: protocol for a living systematic review (full–2018)
https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0761-2
Evidence for THC versus CBD in cannabinoids (full-2018)  http://www.cfp.ca/content/64/7/519.long

Therapeutic Use of medicinal cannabis in difficult to manage epilepsy (full-2018) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13711

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor (full–2018) https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-018-0395-2

Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis (full–2018) https://www.frontiersin.org/articles/10.3389/fneur.2018.00759/full

Cannabidiol for Treatment of Childhood Epilepsy-A Cross-Sectional Survey (full–2018) https://www.frontiersin.org/articles/10.3389/fneur.2018.00731/full

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age (full–2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full

The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus (full–2018) https://www.sciencedirect.com/science/article/pii/S0920121118302201?via%3Dihub

Interaction between warfarin and cannabis (full–2018) https://onlinelibrary.wiley.com/doi/full/10.1111/bcpt.13152

Efficacy of cannabinoids in paediatric epilepsy (full–2018) https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14087
A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144444/
Cannabis Therapeutics and the Future of Neurology (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200872/
Epilepsy and Cannabis: A Literature Review (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235654/
Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence (abst–2018)
https://jnnp.bmj.com/content/89/7/741.long
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome (abst–2018) https://www.nejm.org/doi/full/10.1056/NEJMoa1714631

Cannabis in palliative care: current challenges and practical recommendations (full-2018) http://apm.amegroups.com/article/view/20097/21242

Erratum to cannabis in palliative care: current challenges and practical recommendations (erratum–2018) http://apm.amegroups.com/article/view/23880/23545

FDA approves its first cannabis based medicine (full–2018) https://www.bmj.com/content/361/bmj.k2827.full

Cannabidiol for Epilepsy: New Hope on the Horizon? (full–2018) https://www.clinicaltherapeutics.com/article/S0149-2918(18)30325-4/fulltext
Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order (full–2018) https://www.federalregister.gov/documents/2018/09/28/2018-21121/schedules-of-controlled-substances-placement-in-schedule-v-ofcertain-fda-approved-drugs-containing

Cannabis Oil in an Irish Children’s Critical Care Unit (full–2018) http://imj.ie/cannabis-oil-in-an-irish-childrens-critical-care-unit/

Treatment of infantile spasms (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293071/

Plants come to mind: phytocannabinoids, endocannabinoids and the control of seizures (full–2018) https://onlinelibrary.wiley.com/doi/full/10.1111/add.14540

Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities (link to PDF–2018) https://www.researchgate.net/publication/322709612_Prospects_of_Cannabidiol_for_Easing_Status_EpilepticusInduced_Epileptogenesis_and_Related_Comorbidities

Cannabis for the Treatment of Epilepsy: an Update (link to PDF–2018) https://www.researchgate.net/publication/324263327_Cannabis_for_the_treatment_of_paediatric_epilepsy_An_update_for_Canadian_paediatricians

Practical considerations in medical cannabis administration and dosing (link to PDF–2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing

Species-specific susceptibility to cannabis-induced convulsions (download–2018) http://centaur.reading.ac.uk/75676/9/Whalley_et_al-2017-British_Journal_of_Pharmacology.pdf

The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next (link to download-article-2018) https://cha.com/wp-content/uploads/2018/10/3.5.5-jama_Rubin_2018_mn_180050-1.pdf

Cannabinoids: just like any other medication? (article–2018) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31611-8/fulltext

Safety of cannabidiol prescribed for children with refractory epilepsy (letter–2018) https://www.mja.com.au/journal/2018/209/5/safety-cannabidiol-prescribed-children-refractory-epilepsy

Cannabis, cannabis everywhere: UK to review medical cannabis policy as Canada plans imminent legalisation for all uses (1st page of editorial–2018) https://www.bmj.com/content/361/bmj.k2695.long

Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice (abst–2018) https://www.semanticscholar.org/paper/Arvanil%2C-olvanil%2C-AM-1172-and-LY-2183240-(various-TutkaWla%C5%BA/7a78fa93122b8296e83888c29e0ab5325d2fb6fd

Medical cannabis: “restrictive” guidance lets patients down, say campaigners (abst–2018) https://www.bmj.com/content/363/bmj.k4654.full

Intoxication From Accidental Marijuana Ingestion in Pediatric Patients: What May Lie Ahead (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29406477
Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice (abst–2018)
http://www.seizure-journal.com/article/S1059-1311(17)30611-8/fulltext
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in
children and adolescents – An observational, longitudinal study (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29674131
Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling (abst–2018) https://www.semanticscholar.org/paper/Control-of-excessive-neural-circuit-excitability-of-SugayaKano/eed24a7f27095740ad9b111c3df29735a2c777c6
Endocannabinoid CB1 receptors are involved in antiepileptogenic effect of low frequency electrical stimulation during perforant path kindling in rats (abst–2018)
https://www.sciencedirect.com/science/article/pii/S0920121117304291?via%3Dihub
Investigational cannabinoids in seizure disorders, what have we learned thus far?
(abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/29842819

TRPV1 mediates the anticonvulsant effects of acetaminophen in mice (abst–2018) https://www.sciencedirect.com/science/article/pii/S0920121118300573?via%3Dihub

Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis (abst–2018) https://link.springer.com/article/10.1007%2Fs40263-018-0558-9

Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303277

Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303344

Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats (abst–2018) https://link.springer.com/article/10.1007%2Fs12640-018-9944-9

Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model (abst–2018) https://www.semanticscholar.org/paper/Inhibitions-of-anandamide-transport-and-FAAH-and-of-Naz%C4%B1ro%C4%9FluTaner/fc43de120f4b6bce503fe59ae74b4f37be7c09e4

Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30169677

Acute foot-shock stress decreased seizure susceptibility against pentylenetetrazole induced seizures in mice: Interaction between endogenous opioids and cannabinoids (abst–2018) https://www.epilepsybehavior.com/article/S1525-5050(17)30777-1/fulltext

Marijuana’s Effects on Brain Structure and Function: What Do We Know and What Should We Do? A Brief Review and Commentary (abst–2018) https://www.amjmed.com/article/S0002-9343(18)30872-6/fulltext

Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer (abst–2018) https://www.jem-journal.com/article/S0736-4679(18)30928-4/fulltext
Cannabis and epilepsy (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30337476

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and MetaAnalysis (abst–2018) https://link.springer.com/article/10.1007%2Fs40265-018-0992-5

Medical cannabis: A needs analysis for people with epilepsy (abst–2018) https://www.sciencedirect.com/science/article/pii/S1744388118302354?via%3Dihub

The US Food and Drug Administration’s Authorization of the First Cannabis-Derived Pharmaceutical – Are We Out of the Haze? (abst–2018) https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720

Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30455572

The level of evidence of medical marijuana use for treating disabilities: a scoping review (abst–2018) https://www.tandfonline.com/doi/abs/10.1080/09638288.2018.1523952

Simultaneous quantification of thirteen cannabinoids and metabolites in human plasma by liquid chromatography tandem mass spectrometry in adult epilepsy patients (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30520828

Cannabis based drugs: how will they be used in practice? (abst–2018) https://www.bmj.com/content/363/bmj.k4665.long

Cannabis-based products for pediatric epilepsy: A systematic review (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/epi.14608

The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain (full–2019) https://www.frontiersin.org/articles/10.3389/fpls.2018.01969/full

US Veterinarians’ Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338022/

Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy? (full–2019) https://www.sciencedirect.com/science/article/pii/S2213323218301567?via%3Dihub

Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan) (full–2019) https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514

Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396837/

Review of the many faces of synthetic cannabinoid toxicities (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations (full–2019) https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-019-0990-z#Abs1Medicinal use of cannabis based products and cannabinoids (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447998/

Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity (full–2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00226/full

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514832/

Why I campaign for children like my son Alfie Dingley to be able to get medical cannabis (full–2019) https://www.bmj.com/content/365/bmj.l1921.long

Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy (full–2019) https://link.springer.com/article/10.1007%2Fs40263-019-00624-4

Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533278/

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study (full–2019) https://www.frontiersin.org/articles/10.3389/fneur.2019.00716/full

The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study (full–2019) https://www.epilepsybehavior.com/article/S1525-5050(19)30305-1/fulltext

Investigating the Therapeutic Mechanism of Cannabidiol in a Human Induced Pluripotent Stem Cell (iPSC)-Based Cellular Model of Dravet Syndrome (download–2019) http://symposium.cshlp.org/content/early/2019/06/11/sqb.2018.83.038174.long

Why medical cannabis is still out of patients’ reach-an essay by David Nutt (U.K.) (click “psprings” for download–2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Why+medical+cannabis+is+still+out+of+patients%27+reachan+essay+by+David+Nutt.&btnG

Medical cannabis: no NHS patients have benefited from law change, say campaigners (1st page-2019) https://www.bmj.com/content/364/bmj.l753

The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30919712

Epidiolex (Cannabidiol): A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30616501

Cannabinoid therapy in epilepsy (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30676535

A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and Potential (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563

Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder (abst–2019) https://www.sciencedirect.com/science/article/pii/S0920121118306107?via%3Dihub

Improving post-hypoxic myoclonus using cannabidiol (abst–2019) https://www.seizure-journal.com/article/S1059-1311(18)30573-9/fulltext

Reclassifying cannabis based drugs has not made accessing them easier, MPs hear (abst–2019) https://www.bmj.com/content/364/bmj.l1302.long

Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30910443

Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30938373

Disposition of oral delta-9 tetrahydrocannabinol (THC) in children receiving cannabis extracts for epilepsy (abst–2019) https://www.tandfonline.com/doi/abs/10.1080/15563650.2019.1616093?journalCode=ictx20

Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31160106

Crossing the Line: Care of a Pediatric Patient with Intractable Seizures and Severe Neuropathic Pain in Absence of Access to Medical Marijuana (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31184974

Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. (important) (abst–2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/epi.16093

Marijuana use among patients with epilepsy at a tertiary care center (Oregon) (abst–2019) https://www.epilepsybehavior.com/article/S1525-5050(19)30222-7/fulltext

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31372958

Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center (abst–2019) https://www.epilepsybehavior.com/article/S1525-5050(19)30538-4/fulltext


ESSENTIAL TREMOR
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071561/

Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27545646
Effect of marijuana on Essential Tremor: A case report (abst–2016) http://www.mdsabstracts.org/abstract/effect-of-marijuana-on-essential-tremor-a-case-report/


ETHICS and CANNABIS

Bioethical analysis to the therapeutic use of Cannabis: Integrative review (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0969733017703699

https://www.semanticscholar.org/paper/Bioethical-analysis-to-the-therapeutic-use-of-VasconcelosSilva/ad2d2a17b489a983063db23cd856a3d5ea1f5ccb

Ethical Issues Arising from Marijuana Use by Nursing Mothers in a Changing Legal and Cultural Context (abst–2018) https://link.springer.com/article/10.1007%2Fs10730-018-9368-1

Ethical issues in medical cannabis use (abst–2018) https://www.ejinme.com/article/S0953-6205(18)30016-5/fulltext

Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30610100

Cannabis money opens new opportunities, and ethical dilemmas, for medical research (full–2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379174/


EXERCISE and the ENDOCANNABINOID SYSTEM*+
A runner’s high depends on cannabinoid receptors in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620874/
Runner’s high linked to cannabinoid receptors in mice (news & abstract–2015)  http://medicalxpress.com/news/2015-10-runner-high-linked-cannabinoid-receptors.html
Cannabinoid Receptor 1 and Acute Resistance Exercise – In vivo and In vitro Studies in Human Skeletal Muscle (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796352
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26447738

Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions (abst–2015) http://link.springer.com/article/10.1007/s40279-015-0362-
Neuromodulation of Aerobic Exercise—A Review (full–2016) http://journal.frontiersin.org/article/10.3389/fpsyg.2015.01890/full
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to 
cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082783/
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305303/
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26880264
Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26812592
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
top
The role of exercise training and the endocannabinoid system in atherosclerotic plaque  burden and composition in Apo-E-deficient mice (full–2017)  http://www.sciencedirect.com/science/article/pii/S1109966616302949
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Cannabis: Exercise performance and sport. A systematic review (full–2017) 
http://www.jsams.org/article/S1440-2440(17)30342-0/fulltext
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat (full–2017) 
http://www.sciencedirect.com/science/article/pii/S0014299917307239?via%3Dihub
Anxious behavior induces elevated hippocampal Cb2 Receptor gene expression (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482502/
Running Out of Options: Rhabdomyolysis Associated with Cannabis Hyperemesis
Syndrome (full–2017) 
https://link.springer.com/article/10.1007%2Fs11606-017-4111-1
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity 

Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28387833
Exercise versus targeting of endocannabinoid system for atheromatic plaque stabilization. Opposing or complementary roles? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1109966617301422
AMPK contributes to aerobic exercise-induced antinociception downstream of 
endocannabinoids (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301983?via%3Dihub
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28561272
Voluntary exercise improves cognitive deficits in female dominant-negative DISC1 
transgenic mouse model of neuropsychiatric disorders (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15622975.2017.1323118?journalCode=iwbp20
Moderate and vigorous physical activity patterns among marijuana users: Results from the 2007-2014 National Health and Nutrition Examination Surveys (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30275-2/fulltext
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/28653665
Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29388710
Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced COPD: A Randomized Controlled Trial (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/30049223

Endogenous systems involved in exercise-induced analgesia (click “Full Text Links” for download–2018) https://www.ncbi.nlm.nih.gov/pubmed/29769416
Effects of exercise on experimentally manipulated craving for cannabis: A preliminary study (abst–2018) http://psycnet.apa.org/record/2018-23654-001
Seasonal Changes in Endocannabinoid Concentrations between Active and Hibernating Marmots (Marmota flaviventris) (abst–2018)
http://journals.sagepub.com/doi/abs/10.1177/0748730418777660?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
A Behavioral Economic Analysis of Marijuana and Other Drug Use Among Heavy
Drinking Young Adults (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29930973

Endocannabinoids, exercise, pain, and a path to health with aging (abst–2018) https://www.sciencedirect.com/science/article/pii/S0098299718300359?via%3Dihub

Aerobic Fitness Level Moderates the Association Between Cannabis Use and Executive Functioning and Psychomotor Speed Following Abstinence in Adolescents and Young Adults (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/30474579

The New Runner’s High? Examining Relationships Between Cannabis Use and Exercise Behavior in States With Legalized Cannabis (full–2019) https://www.frontiersin.org/articles/10.3389/fpubh.2019.00099/full

The Endocannabinoid System as a Potential Mechanism through which Exercise Influences Episodic Memory Function (full–2019) https://www.mdpi.com/2076-3425/9/5/112/htm

The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors (full–2019) https://insight.jci.org/articles/view/126190

Is Cannabis Use Associated with Sedentary Behavior during Leisure Time? A Study in Canada, 2011-2012 (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30658548

Performance and Health-Related Characteristics of Physically Active Males Using Marijuana (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/29023325

Diet, endocannabinoids, and health (abst–2019) https://www.sciencedirect.com/science/article/pii/S027153171930572X?via%3Dihub

Chronic aerobic exercise: Lack of effect on brain CB1 receptor levels in adult rats (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S002432051930414X?via%3Dihub

Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD (abst–2019) https://www.sciencedirect.com/science/article/pii/S0301051119300110?via%3Dihub

Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/30973483
top


Updated 28 September 2019